In light of the unique challenges that rare disease companies face within the broader pharmaceuticals sector, the Rare Disease Compliance Consortium was founded to uplift the voice of rare disease community patients and advance compliance excellence among its peer members.
Please note that the views expressed and the content included in this page are solely those of the RDCC and should not be attributed to the opinions, positions, or business of Paul Hastings or any RDCC member companies.
Company Details
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Competitors
- Rare Disease Foundation, Hypertrophic Cardiomyopathy Association, Rare Disease Clinical Trial Network, HER HEALTHX, Rare Disease Therapeutics, Inc., iHealth, PHARMACEUTICAL COMPLIANCE FORUM INC, Global Genes, Rare Disease Diversity Coalition, Professional Patient Advocates in Life Sciences (PPALS).
Rare Disease Compliance Consortium (Rdcc) Questions
Rare Disease Compliance Consortium (Rdcc)'s LinkedIn profile is https://www.linkedin.com/company/rare-disease-compliance-consortium-rdcc
Rare Disease Compliance Consortium (Rdcc)'s industry is
Pharmaceutical Manufacturing
Rare Disease Compliance Consortium (Rdcc)'s top competitors are
Rare Disease Foundation,
Hypertrophic Cardiomyopathy Association,
Rare Disease Clinical Trial Network,
Her Healthx,
Rare Disease Therapeutics, Inc.,
Ihealth,
Pharmaceutical Compliance Forum Inc,
Global Genes,
Rare Disease Diversity Coalition,
Professional Patient Advocates In Life Sciences (Ppals).
Rare Disease Compliance Consortium (Rdcc)'s categories are Pharmaceutical Manufacturing
